Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy

Jie Mei , Xingjian Liu , Hui-Xiang Tian , Yixuan Chen , Yang Cao , Jun Zeng , Yung-Chiang Liu , Yaping Chen , Yang Gao , Ji-Ye Yin , Peng-Yuan Wang

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (4) : e1656

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (4) : e1656 DOI: 10.1002/ctm2.1656
REVIEW

Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy

Author information +
History +
PDF

Abstract

• The current PDTO models have not yet constructed key cellular and noncellular components.

• PDTOs should be expandable and editable.

• PDTOs are promising preclinical models for immunotherapy unless mature PDTOs can be established.

• PDTO biobanks with consensual standards are urgently

Keywords

organoid / assembloid / cell therapy / immunotherapy / PDTO biobank

Cite this article

Download citation ▾
Jie Mei,Xingjian Liu,Hui-Xiang Tian,Yixuan Chen,Yang Cao,Jun Zeng,Yung-Chiang Liu,Yaping Chen,Yang Gao,Ji-Ye Yin,Peng-Yuan Wang. Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy. Clinical and Translational Medicine, 2024, 14(4): e1656 DOI:10.1002/ctm2.1656

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/